Bafna Pharmaceuticals Limited (BAFNAPH.NS) NSE

142.30

-2.89(-1.99%)

Updated at December 05 10:14AM

Currency In INR

Valuation

Market Cap1.77B
Enterprise Value2.02B
P/E Ratio41.63
PEG Ratio0.42
Price/Sales Ratio2.33
Price/Book Ratio4.06
Enterprise/Revenue2.33
Enterprise/EBITDA21.38

Fiscal Year

Fiscal YearMarch 31, 2025
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin0.06
Operating Margin0.07

Management Effectiveness

Return On Assets0
Return On Equity0.1

Income Statement

Revenue1.46B
Revenue/Share62.11
Gross Profit168.77M
EBITDA117.74M
Net Income41.53M
Diluted EPS1.76

Balance Sheet

Total Cash34.33M
Total Cash/Share0
Total Debt0
Total Debt/Equity0
Current Ratio0
Book Value Per Share35.79

Price History

52-Week Change77.65
52-Week High202.06
52-Week Low69
Moving Average 50 Days160.11
Moving Average 200 Days103.46

Statistics

Average Volume13,656
Shares Outstanding23.66M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:10
Last Split DateAugust 26, 2019